RESUMEN
We evaluated the time course of osteoinduction by an adenoviral vector, AxCAOBMP-2, in normal rats (Group I) and 2 immunosuppressed groups (Groups II and III). Immunosuppression was induced by 125 mg/kg of cyclophosphamide injected intraperitoneally the day before vector injection. Groups I and III received a high dose of AxCAOBMP-2 (25 microl; 8.75 x 10(8) pfu) and Group II a low dose (5 microl; 1.75 x 10(8) pfu). Each dose of AxCAOBMP-2 was injected into the right calf muscle of rats. On days 7, 14 and 21 postinjection, the osteoinducive activity in each group was investigated radiologically, histologically, immunohistochemically and biochemically. Osteoinduction was observed only in Groups II and III on days 14 and 21. The activity of osteoinduction in Group III was higher than that in Group II. There was little difference in the expression of LacZ between Groups I and III on day 3. However, there was a marked difference in BMP-2 protein expression between Groups I and III on day 7 postinjection. We speculated that the reason for this was that most of the infected cells were eliminated by the immune system of the host from days 3 to 7. These results suggest that gene therapy with AxCAOBMP-2 under transient immunosuppression may be useful for bone reconstruction.
Asunto(s)
Adenoviridae/genética , Proteínas Morfogenéticas Óseas/genética , Terapia Genética , Osteogénesis , Factor de Crecimiento Transformador beta , Fosfatasa Alcalina/metabolismo , Animales , Proteína Morfogenética Ósea 2 , Calcio/análisis , Ciclofosfamida/farmacología , Vectores Genéticos , Inmunohistoquímica , Masculino , Ratas , Ratas WistarRESUMEN
The purpose of current study was to determine the step at which dietary selenium (Se) regulates the transcriptional expression of the gene for Se-glutathione peroxidase (Se-GPx) in rat brain and transplanted glioma tissue. Wistar rats were fed a Se-free diet or the same diet supplemented with 0.5, 2.0, and 4.0 mg Se/kg as sodium selenite for at least 3 wk. Then, the rats were transplanted with C6 rat glioma cells into the right frontal lobe parenchyma. All rats were observed for 30 d, then tumor and contralateral brain tissue were excised and divided into three portions for purification of selenium content, for the assay of Se concentration, Se-GPx activity, and for Se-GPx mRNA. Se concentration and Se-GPx activity are increased with Se supplementation both in tumor tissue and contralateral brain tissue, and Se concentration in tumor is higher than that in contralateral brain tissue at each dietary Se content. Se-GPx mRNA of brain and tumor were probed with fragments from a rat Se-GPx cDNA in Northern blot analysis. There was significant differences of Se-GPx mRNA transcription in brain tumor tissue among each dietary group of the Se content, and the steady-state level of Se-GPx mRNA was markedly reduced by Se deficiency. These results suggest that dietary Se exerts its augmenting effect on Se-GPx gene transcription.
Asunto(s)
Encéfalo/metabolismo , Glioma/metabolismo , Glutatión Peroxidasa/metabolismo , ARN Mensajero/metabolismo , Selenio/metabolismo , Animales , Northern Blotting , ADN Complementario/metabolismo , Relación Dosis-Respuesta a Droga , Masculino , Trasplante de Neoplasias , Ratas , Ratas Wistar , Selenio/farmacología , Transcripción Genética/efectos de los fármacosRESUMEN
Antigen recognition through T cell receptor (TCR)-CD3 complex transduces signals into T cells, which regulate activation, function, and differentiation of T cells. The TCR-CD3 complex is composed of two signaling modules represented by CD3zeta and CD3epsilon. Signaling through CD3zeta has been extensively analyzed, but that via CD3epsilon, which is also crucial in immature thymocyte development, is still not clearly understood. We isolated cDNA encoding a novel CD3epsilon-binding protein CAST. CAST specifically interacts in vivo and in vitro with CD3epsilon but not with CD3zeta or FcRgamma via a unique membrane-proximal region of CD3epsilon. CAST is composed of 512 amino acids including a single tyrosine and undergoes tyrosine phosphorylation upon TCR stimulation. Overexpression of two dominant-negative types of CAST, a minimum CD3epsilon-binding domain and a tyrosine-mutant, strongly suppressed NFAT activation and interleukin-2 production. These results demonstrate that CAST serves as a component of preformed TCR complex and transduces activation signals upon TCR stimulation and represents a new signaling pathway via the CD3epsilon-containing TCR signaling module.
Asunto(s)
Complejo CD3 , Proteínas Portadoras/química , Proteínas Portadoras/fisiología , Interleucina-2/biosíntesis , Péptidos y Proteínas de Señalización Intracelular , Receptores de Antígenos de Linfocitos T/metabolismo , Linfocitos T/metabolismo , Activación Transcripcional , Secuencia de Aminoácidos , Animales , Sitios de Unión , ADN Complementario/química , Humanos , Células Jurkat , Ratones , Datos de Secuencia Molecular , Fosforilación , ARN Polimerasa I , Transducción de Señal , Células Tumorales Cultivadas , Tirosina/metabolismoRESUMEN
The potential of 111Indium (111In)-labelled internalising anti-integrin alpha 3 antibody GA17 in the radioimmunotherapy of human glioblastoma xenografts in nude mice was investigated. A radioisotope retention assay showed a rapid release of radioiodine from the glioblastoma cells after the binding of 125I-GA17, whilst 111In-GA17 was retained in the cells for a longer time period. The glioblastoma xenografts showed a high and prolonged uptake of 111In-GA17, and tumour uptake of 125I-GA17 was lower and decreased with time. In the mice which received two injections of 18.5 MBq of 111In-GA17, the growth of the subcutaneous tumour was significantly suppressed compared with the untreated group and mice injected with an 111In-labelled control antibody. These results indicate that GA17 was internalized into the glioblastoma cells and that 111In was retained within the cancer cells. The injection of a high-dose of 111In-GA17 can suppress the growth of tumour xenografts in nude mice.
Asunto(s)
Anticuerpos Monoclonales/uso terapéutico , Glioblastoma/radioterapia , Radioisótopos de Indio/uso terapéutico , Radioinmunoterapia/métodos , Animales , Anticuerpos Monoclonales/farmacocinética , División Celular , Glioblastoma/metabolismo , Glioblastoma/patología , Humanos , Radioisótopos de Indio/farmacocinética , Radioisótopos de Yodo/farmacocinética , Radioisótopos de Yodo/uso terapéutico , Ratones , Ratones Desnudos , Trasplante de Neoplasias , Trasplante HeterólogoRESUMEN
A case of treatment-related leukoencephalopathy is presented. A patient with medulloblastoma was postoperatively treated with craniospinal axis irradiation. One month after irradiation, weekly intrathecal administration of methotrexate was performed 4 times to treat cerebrospinal fluid dissemination of the tumor. Two months after the initiation of intrathecal chemotherapy, the patient became somnolent and developed decerebrate posturing. Magnetic resonance imaging showed diffuse leukoencephalopathy. Positron emission tomography revealed a diffuse decrease in glucose uptake in the deep white matter. Auditory evoked potential also showed diffuse abnormalities, not only in the cerebrum, but also in the brain stem. High dose intravenous leucovorin rescue was attempted without any neurologic improvement.
Asunto(s)
Daño Encefálico Crónico/etiología , Encefalopatías/etiología , Neoplasias Cerebelosas/terapia , Irradiación Craneana/efectos adversos , Diagnóstico por Imagen , Meduloblastoma/terapia , Metotrexato/efectos adversos , Traumatismos por Radiación/etiología , Proteínas Sanguíneas/análisis , Daño Encefálico Crónico/diagnóstico , Daño Encefálico Crónico/tratamiento farmacológico , Daño Encefálico Crónico/patología , Encefalopatías/diagnóstico , Encefalopatías/tratamiento farmacológico , Encefalopatías/patología , Neoplasias Cerebelosas/tratamiento farmacológico , Neoplasias Cerebelosas/radioterapia , Neoplasias Cerebelosas/cirugía , Proteínas del Líquido Cefalorraquídeo/análisis , Derivaciones del Líquido Cefalorraquídeo , Niño , Terapia Combinada/efectos adversos , Estado de Descerebración/etiología , Femenino , Humanos , Inyecciones Espinales , Leucovorina/uso terapéutico , Imagen por Resonancia Magnética , Meduloblastoma/tratamiento farmacológico , Meduloblastoma/radioterapia , Meduloblastoma/cirugía , Metotrexato/administración & dosificación , Tomografía Computarizada de Emisión , Tomografía Computarizada por Rayos XRESUMEN
Two established osteogenic cell lines (NY, MC 3 T3-E 1) were used in vitro to determine the biocompatibility of glass ceramics and their effect on initial calcification of osteogenic cells. Morphological study of the cell under the phase-contrast microscopy and histochemical staining were applied as follows. First, glass ceramic granules were placed in 60 mm dishes, and cells were suspended in the dishes in alpha-MEM supplemented with 10% FBS (basic medium) or medium with 50 micrograms/ml of L-ascorbic acid added. After 8 or 14 day of culturing, calcium formation was tested by von-Kossa's staining. Also, alkaline phosphatase staining was performed by the azo-dye method. As controls, cultures in dishes without glass ceramic granules were stained at the same time. The results obtained in the experimental culture were as follows. 1. Phase contrast microscopy showed that contacts with glass ceramics did not cause cellular death or degeneration. 2. In both cell cultures with the glass ceramics the von-Kossa reaction was positive as early as the 8th day. 3. The alkaline phosphatase reaction on the 8th day occurred only in MC 3 T3-E 1. The reaction was localized on fibroblastic cells which proliferated three-dimensionally around glass ceramics, and on small polyhedral cells situated relatively for apart from the ceramics. 4. On the 14th day, the MC 3 T 3-E 1 formed large nodules around the glass ceramics, and they were stained uniformly positive by von-Kossa's method. The alkaline phosphatase-positive cells extended spoke-like forms. 5. In medium with L-ascorbic acid, growth of NY was inhibited, After being cultured for 14 days, abundant von-Kossa positive reaction was found around glass ceramics in both cells. In MC 3 T 3-E1 on the 8th days, the alkaline phosphatase reaction was stronger with glass ceramics than with basic medium only. On the contrary, in the control cultures of both cells there was negative von-Kossa reaction during the culture period. The above results showed that glass ceramic granules have the biocompatibility needed for bone grafts, and they facilitated calcification of MC 3 T 3-E 1 in culture.